ODONATE THERAPEUTICS INC has a total of 13 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and Australia. Its main competitors in its focus markets pharmaceuticals are ROBINSON CYNTHIA B, BELMAC S A LAB and SALMON PHARMA GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Taiwan | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Tang Kevin | 11 |
#2 | Pfeiffer Steven | 11 |
#3 | Wei Thomas | 11 |
#4 | Kroll Stew | 11 |
#5 | Vacirca Jeff | 10 |
#6 | Lemkey John G | 6 |
#7 | Lemkey John | 4 |
#8 | James Joyce | 3 |
#9 | Lemkdy John G | 1 |
#10 | Jeff Vacirca | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020081165A1 | Methods of treating cns tumors with tesetaxel | |
WO2021034335A1 | Methods of administering tesetaxel with glucocorticoids that are cyp3a4 inducers | |
AU2018275122A1 | Dosing schedule for tesetaxel and capecitabine |